Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Researchers Offer Hope for a Genital Herpes Vaccine for Women
New York Times; A24


A 19-month study, conducted by Lawrence R. Stanberry of the University of Texas Medical Branch and colleagues, involved 978 women and 1,736 men whose partners had genital herpes. The trial determined that GlaxoSmithKline's experimental genital herpes vaccine showed promise in protecting women against the sexually transmitted disease. Participants in the study received either three injections of the vaccine or three injections of a placebo during the first six months of the study. The drug company will conduct a larger study involving women between the ages of 18 years and 30 years to make more specific determinations about the vaccine's prevention success rate. Stanberry, whose findings were published Thursday in the New England Journal of Medicine, believes the vaccine will help prevent neonatal herpes, which infects up to 3,000 newborns per year and is often fatal if not aggressively treated.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.